JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

Benzinga · 2d ago
JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.